GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Ergo Science Corp (GREY:ERGN) » Definitions » COGS-to-Revenue

Ergo Science (Ergo Science) COGS-to-Revenue : 0.70 (As of Sep. 2006)


View and export this data going back to . Start your Free Trial

What is Ergo Science COGS-to-Revenue?

Ergo Science's Cost of Goods Sold for the three months ended in Sep. 2006 was $6.53 Mil. Its Revenue for the three months ended in Sep. 2006 was $9.31 Mil.

Ergo Science's COGS to Revenue for the three months ended in Sep. 2006 was 0.70.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Ergo Science's Gross Margin % for the three months ended in Sep. 2006 was 29.87%.


Ergo Science COGS-to-Revenue Historical Data

The historical data trend for Ergo Science's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ergo Science COGS-to-Revenue Chart

Ergo Science Annual Data
Trend Dec96 Dec97 Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.85 0.76 0.66

Ergo Science Quarterly Data
Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 - 0.87 0.71 0.70

Ergo Science COGS-to-Revenue Calculation

Ergo Science's COGS to Revenue for the fiscal year that ended in Dec. 2005 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=18.765 / 28.399
=0.66

Ergo Science's COGS to Revenue for the quarter that ended in Sep. 2006 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=6.53 / 9.311
=0.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ergo Science  (GREY:ERGN) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Ergo Science's Gross Margin % for the three months ended in Sep. 2006 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 6.53 / 9.311
=29.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Ergo Science COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ergo Science's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Ergo Science (Ergo Science) Business Description

Traded in Other Exchanges
N/A
Address
402 Office Park Drive, Suite 260, Birmingham, AL, USA, 35223
Ergo Science Corp is a United States based workforce injury prevention and treatment provider. It is focused on employee safety and employer risk reduction. The company offers physical abilities tests built from defensible, peer-reviewed research; evidence-based injury prevention and rehabilitation for diversified businesses.
Executives
Citigroup Inc director 388 GREENWICH STREET, NEW YORK NY 10013
Iticorp director 399 PARK AVENUE, NEW YORK NY 10043
Citicorp Banking Corp director ONE PENNS WAY, NEW CASTLE DE 19720
Citigroup Holdings Co director 336 THE STRAND, LONDON ENGLAND
Court Square Capital Ltd director 399 PARK AVE, NEW YORK NY 10043

Ergo Science (Ergo Science) Headlines

No Headlines